Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-20EMA Authorised: MabThera (rituximab) — Roche Registration GmbH
EMA authorization of MabThera (rituximab) for multiple indications including non-Hodgkin lymphoma, rheumatoid arthritis, and chronic lymphoc…
-
EMA approval · 2026-08-06EMA Authorised: MabThera (rituximab) — Roche Registration GmbH
EMA authorised MabThera (rituximab) by Roche Registration GmbH for multiple indications including non-Hodgkin lymphoma, rheumatoid arthritis…
-
CLINICAL_TRIALS research · 2026-07-02Clinical Trial Results: Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health [NA]
Clinical trial results for adapting multiple behavior interventions to improve cancer survivor health; completed with results posted.
-
CLINICAL_TRIALS trial_result · 2026-06-26Clinical Trial Results: A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adults With Hodgkin and Non-Hodgkin Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating safety, tolerability, drug levels, and preliminary efficacy of relatlimab plus nivolumab in pediatric and young a…
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Anti-CD22 Chimeric Receptor T Cells in Pediatric and Young Adults With Recurrent or Refractory CD22-expressing B Cell Malignancies [Phase 1]
Phase 1 trial evaluating anti-CD22 CAR T cells in pediatric and young adult patients with recurrent or refractory CD22-expressing B-cell mal…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Methionine PET/CT Studies In Patients With Cancer [Phase 2]
Phase 2 methionine-based PET/CT imaging studies in patients with various cancers; the trial is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment
NCI-sponsored clinical trial update describes collecting human samples to study hairy cell leukemia and other leukemias, and to develop reco…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic Cancer
An NCI-sponsored trial characterizes individuals and families at high risk of hematologic cancers, focusing on conditions including Waldenst…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies
This clinical trial entry describes a study to establish a tumor bank in families with multiple lymphoproliferative malignancies and is curr…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Tissue Collection for Studies of Lymph Cancer
Clinical trial update describing tissue collection for studies of lymph cancers; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
This clinical trial update describes ongoing specimen collection from participants with HIV infection, KSHV infection, and virus-related pre…
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: A Clinical Study Exploring the Safety, Efficacy and Metabolic Kinetics of CT1182 Injection in Patients With Relapsed / Refractory Non Hodgkin Lymphoma [EARLY_Phase 1]
Early-phase clinical trial update on the safety, efficacy and metabolic kinetics of CT1182 injection in relapsed/refractory non-Hodgkin lymp…
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Testing the Safety of the Anti-cancer Drugs Tazemetostat and Belinostat in Patients With Lymphomas That Have Resisted Treatment [Phase 1]
Phase 1 trial to assess the safety of the anti-cancer drugs tazemetostat and belinostat in patients with recurrent or refractory lymphomas; …
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: AI-based Predictive and Interventional System for Early Detection of Non-compliance Risks With Oral Therapies in Lymphoma Patients.
A clinical trial evaluating an AI-based predictive and interventional system to detect non-compliance risks with oral therapies in Non-Hodgk…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies [Phase 1, Phase 2]
This is a Phase 1/2 dose-escalation and expansion study of BGB-16673 in patients with various B-cell malignancies and is currently recruitin…
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: Identifying Immune-related Biomarkers to Predict the Efficacy of Cancer Immunotherapy [NA]
This clinical trial update reports completion of a study to identify immune-related biomarkers that predict the efficacy of cancer immunothe…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Biology Studies of Hematologic Cancers
The document reports an NCI-sponsored biology-focused clinical trial update in hematologic cancers, with enrollment by invitation for condit…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies. [Phase 1, Phase 2]
This document describes a Phase 1/Phase 2 clinical trial evaluating AZD3470 as a monotherapy or in combination with other anticancer agents …
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers [Phase 1]
This document outlines an ongoing Phase 1 trial evaluating NKX019, an allogeneic CAR NK cell therapy, in adults with B-cell cancers includin…
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: Genome Expression in Lymphoma, Leukemia and Multiple Myeloma
A completed clinical trial update detailing a genome expression study in leukemia, multiple myeloma, and lymphomas (Hodgkin and Non-Hodgkin)…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma [Phase 2]
A Phase 2 clinical trial is evaluating acalabrutinib in combination with DA-EPOCH-R or R-CHOP for patients with untreated diffuse large B-ce…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma [Phase 1, Phase 2]
This document outlines a Phase 1/2 clinical trial (ViPOR) evaluating a combination of venetoclax, ibrutinib, prednisone, obinutuzumab, and l…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma [Phase 1]
A Phase 1 study evaluating safety, pharmacokinetics, and efficacy of mosunetuzumab or glofitamab in combination with CC-220 and/or CC-99282 …
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing
A clinical trial update describing leukapheresis collection for manufacturing CAR or adoptive cell therapies, with enrollment by invitation …
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Long-Term Safety of Pirtobrutinib in Participants With Previously Treated Types of Blood Cancers [Phase 2]
This clinical trial update summarizes long-term safety data for pirtobrutinib in participants with previously treated blood cancers from a P…